Asel Ananda to Present Bladder Cancer Advancements at ACS 2021

Asel Ananda, co-founder, will present a pioneering biomarker-based bladder cancer test at the ACS National Meeting, August 2021. This innovative research, co-authored with Dr. Thakshila Liyanage, focuses on enhancing follow-up testing and patient outcomes.

August 1, 2021

Latest From News

PR: Early is Good Announces Collaboration with Mayo Clinic to Develop a Comprehensive Liquid Biopsy Test for Men with Advanced Prostate Cancer

April 9, 2024

Early is Good’s founder, Dr. Thakshila Liyanage, will introduce BCDx, a breakthrough in bladder cancer diagnosis test, at the ACS on August 16

July 31, 2023

PR: Early Is Good Raises $4 Million Seed Round from Social Capital

November 2, 2022

We welcome opportunities for strategic partnerships and codevelopment collaborations to leverage our multi-omics platform for research, diagnostic, clinical trials, and pharmaceutical applications.

Early is Good Inc
1210 Waterway Blvd. Ste. 2000,
Indianapolis, IN 46202

Asel Ananda to Present Bladder Cancer Advancements at ACS 2021

Latest From News

PR: Early is Good Announces Collaboration with Mayo Clinic to Develop a Comprehensive Liquid Biopsy Test for Men with Advanced Prostate Cancer

Early is Good’s founder, Dr. Thakshila Liyanage, will introduce BCDx, a breakthrough in bladder cancer diagnosis test, at the ACS on August 16

PR: Early Is Good Raises $4 Million Seed Round from Social Capital

We welcome opportunities for strategic partnerships and codevelopment collaborations to leverage our multi-omics platform for research, diagnostic, clinical trials, and pharmaceutical applications.

(317) 941-6953

Interested in collaborating? Contact us for opportunities in diagnostics, research, and pharma with our multi-omics platform.

Contact Us